Med-IQ
<em>Medical Insiders:</em> Weighing the Evidence for PrEP for HIV Prevention in People Who Inject Drugs
Webcast Webcast

Medical Insiders: Weighing the Evidence for PrEP for HIV Prevention in People Who Inject Drugs


Time to Complete:
30 minutes
Released:
6/2/17
Expires:
6/1/18
PDF:

Maximum Credits:

0.5 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
30 minutes

Released:
6/2/17

Expires:
6/1/18

PDF:

Maximum Credits:
0.5 AMA PRA Category 1 Credit(s)
Share on:
Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
30 minutes
Released:
6/2/17
Expires:
6/1/18
PDF:


Maximum Credits:
0.5 AMA PRA Category 1 Credit(s)


Overview: In this discussion-based Webcast, leading experts in the use of pre-exposure prophylaxis (PrEP) as an HIV-prevention strategy present recent data and provide insight on the potential benefits of implementing this approach to reduce the risk of HIV infection in people who inject drugs.

Faculty

Richard Elion, MD

Associate Professor of Clinical Medicine

George Washington University School of Medicine

Washington, DC

Renata Arrington-Sanders, MD, MPH, ScM

Assistant Professor, Pediatrics

Director,Harriet Lane Clinic Youth-PrEP Clinic

Co-Director, Adolescent and Young Adult Scientific Working Group

Center for AIDS Research

Johns Hopkins University

Medical Director, Pediatric and Adolescent HIV/AIDS Program

Johns Hopkins School of Medicine

Baltimore, MD

Kimberly Page, PhD, MPH

Division Chief, Department of Internal Medicine

Professor, Division of Epidemiology, Biostatistics, and Preventive Medicine

University of New Mexico

Albuquerque, NM


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Renata Arrington-Sanders, MD, MPH, ScM, has indicated no real or apparent conflicts.

Richard Elion, MD
Consulting fees/advisory boards: Gilead Sciences, Inc., Merck & Co., Inc., Viiv Healthcare
Fees received for promotional/non-CME activities: Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Viiv Healthcare
Other (expert witness): Gilead Sciences, Inc.
 
Kimberly Page, PhD, MPH, has indicated no real or apparent conflicts.

The peer reviewers and activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Gilead Sciences, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.